PDB Short entry for 5LCK HEADER TRANSFERASE 22-JUN-16 5LCK TITLE A CLICKABLE COVALENT ERK 1/2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: CYS 129 AND CYS 163 HAVE BEEN MODIFIED IN THE COMPND 10 CRYSTALLISATION SOLUTION TO CME. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS ERK2 COVALENT INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.O'REILLY,D.WRIGHT REVDAT 3 28-MAR-18 5LCK 1 SOURCE REVDAT 2 31-AUG-16 5LCK 1 JRNL REVDAT 1 20-JUL-16 5LCK 0 JRNL AUTH H.LEBRAUD,D.J.WRIGHT,C.E.EAST,F.P.HOLDING,M.O'REILLY, JRNL AUTH 2 T.D.HEIGHTMAN JRNL TITL IN-GEL ACTIVITY-BASED PROTEIN PROFILING OF A CLICKABLE JRNL TITL 2 COVALENT ERK1/2 INHIBITOR. JRNL REF MOL BIOSYST V. 12 2867 2016 JRNL REFN ESSN 1742-2051 JRNL PMID 27385078 JRNL DOI 10.1039/C6MB00367B REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 30041 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 1550 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.020 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2244 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2230 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2137 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE : 0.2520 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 107 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2842 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 484 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.16170 REMARK 3 B22 (A**2) : -2.67550 REMARK 3 B33 (A**2) : 0.51380 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.11500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.210 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.159 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.142 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.136 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3012 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4098 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1060 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 80 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 440 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3000 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 380 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3956 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.98 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|11 - A|365 } REMARK 3 ORIGIN FOR THE GROUP (A): -1.3788 3.3701 38.1333 REMARK 3 T TENSOR REMARK 3 T11: -0.0664 T22: -0.0645 REMARK 3 T33: -0.0627 T12: 0.0070 REMARK 3 T13: -0.0054 T23: -0.0340 REMARK 3 L TENSOR REMARK 3 L11: 1.0014 L22: 0.5684 REMARK 3 L33: 1.1218 L12: -0.2534 REMARK 3 L13: 0.3131 L23: -0.1874 REMARK 3 S TENSOR REMARK 3 S11: -0.0647 S12: -0.1480 S13: 0.1022 REMARK 3 S21: 0.1068 S22: 0.0617 S23: -0.0315 REMARK 3 S31: -0.0866 S32: -0.0450 S33: 0.0031 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT CYCLES USING BUSTER AND REMARK 3 REBUILDS USING COOT REMARK 4 REMARK 4 5LCK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1200000483. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5417 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 105730 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 30.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.44600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M (NH4)2SO4 32% MPEG 2000 .02M REMARK 280 MERCAPTOETHANOL .1M PH=7.2 HEPES/NAOH, PH 7.2, BATCH MODE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.45450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 14 -73.84 -120.04 REMARK 500 ILE A 31 -66.80 -97.72 REMARK 500 TYR A 36 53.04 -145.21 REMARK 500 VAL A 46 -69.04 -93.23 REMARK 500 ARG A 148 -0.73 73.25 REMARK 500 ASP A 149 41.75 -141.50 REMARK 500 ASP A 167 85.37 61.41 REMARK 500 ASN A 201 16.53 -157.83 REMARK 500 LEU A 294 49.63 -96.95 REMARK 500 ASP A 318 89.49 -159.03 REMARK 500 PHE A 331 91.33 -68.44 REMARK 500 MET A 333 0.24 131.42 REMARK 500 LEU A 335 -7.03 -142.22 REMARK 500 PRO A 356 103.83 -50.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 983 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH A 984 DISTANCE = 6.14 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TT A 405 DBREF 5LCK A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQRES 1 A 360 MET ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU MET SEQRES 2 A 360 VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR THR SEQRES 3 A 360 ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET VAL SEQRES 4 A 360 CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL ALA SEQRES 5 A 360 ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR CYS SEQRES 6 A 360 GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE SEQRES 7 A 360 ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG SEQRES 8 A 360 ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE VAL SEQRES 9 A 360 GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU LYS SEQRES 10 A 360 THR GLN HIS LEU SER ASN ASP HIS ILE CME TYR PHE LEU SEQRES 11 A 360 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 360 ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU LEU SEQRES 13 A 360 LEU ASN THR THR CME ASP LEU LYS ILE CYS ASP PHE GLY SEQRES 14 A 360 LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR GLY SEQRES 15 A 360 PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG ALA SEQRES 16 A 360 PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS SER SEQRES 17 A 360 ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU MET SEQRES 18 A 360 LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU SEQRES 19 A 360 ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SEQRES 20 A 360 SER GLN GLU ASP LEU ASN CYS ILE ILE ASN LEU LYS ALA SEQRES 21 A 360 ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS VAL SEQRES 22 A 360 PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS ALA SEQRES 23 A 360 LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO HIS SEQRES 24 A 360 LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR SEQRES 25 A 360 LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE ALA SEQRES 26 A 360 GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP LEU SEQRES 27 A 360 PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU THR SEQRES 28 A 360 ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 5LCK CME A 127 CYS MODIFIED RESIDUE MODRES 5LCK CME A 161 CYS MODIFIED RESIDUE HET CME A 127 10 HET CME A 161 10 HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET 6TT A 405 49 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM 6TT ~{N}-[2-[[2-[(5-METHOXYPYRIDIN-3-YL)AMINO]-5- HETNAM 2 6TT (TRIFLUOROMETHYL)PYRIMIDIN-4- HETNAM 3 6TT YL]AMINO]PHENYL]PROPANAMIDE FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 2 SO4 4(O4 S 2-) FORMUL 6 6TT C20 H19 F3 N6 O2 FORMUL 7 HOH *484(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 LEU A 112 GLN A 119 1 8 HELIX 3 AA3 SER A 122 ALA A 143 1 22 HELIX 4 AA4 LYS A 151 SER A 153 5 3 HELIX 5 AA5 ASP A 175 ASP A 179 5 5 HELIX 6 AA6 THR A 190 ARG A 194 5 5 HELIX 7 AA7 ALA A 195 ASN A 201 1 7 HELIX 8 AA8 LYS A 207 ASN A 224 1 18 HELIX 9 AA9 HIS A 232 GLY A 245 1 14 HELIX 10 AB1 SER A 248 CYS A 254 1 7 HELIX 11 AB2 ASN A 257 LEU A 267 1 11 HELIX 12 AB3 PRO A 274 PHE A 279 1 6 HELIX 13 AB4 ASP A 283 LEU A 294 1 12 HELIX 14 AB5 GLU A 303 ALA A 309 1 7 HELIX 15 AB6 HIS A 310 GLU A 314 5 5 HELIX 16 AB7 ASP A 318 GLU A 322 5 5 HELIX 17 AB8 PRO A 339 THR A 351 1 13 HELIX 18 AB9 ALA A 352 GLN A 355 5 4 SHEET 1 AA1 5 TYR A 25 GLY A 34 0 SHEET 2 AA1 5 GLY A 37 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 AA1 5 VAL A 49 ILE A 56 -1 O VAL A 49 N ASP A 44 SHEET 4 AA1 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 AA1 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 AA2 3 THR A 110 ASP A 111 0 SHEET 2 AA2 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA2 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA3 2 VAL A 145 LEU A 146 0 SHEET 2 AA3 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C ILE A 126 N CME A 127 1555 1555 1.32 LINK C CME A 127 N TYR A 128 1555 1555 1.34 LINK C THR A 160 N CME A 161 1555 1555 1.34 LINK C CME A 161 N ASP A 162 1555 1555 1.35 LINK SG CYS A 166 C25 6TT A 405 1555 1555 1.81 CISPEP 1 GLY A 22 PRO A 23 0 3.25 SITE 1 AC1 8 ARG A 191 ARG A 194 TYR A 233 HOH A 505 SITE 2 AC1 8 HOH A 580 HOH A 627 HOH A 632 HOH A 767 SITE 1 AC2 5 ARG A 67 LEU A 170 ARG A 172 VAL A 188 SITE 2 AC2 5 HOH A 558 SITE 1 AC3 6 LEU A 116 THR A 118 GLN A 119 ASN A 224 SITE 2 AC3 6 HOH A 659 HOH A 780 SITE 1 AC4 4 LYS A 151 SER A 153 HOH A 618 HOH A 745 SITE 1 AC5 16 ILE A 31 VAL A 39 ALA A 52 GLN A 105 SITE 2 AC5 16 ASP A 106 MET A 108 GLU A 109 ASP A 111 SITE 3 AC5 16 LYS A 114 LEU A 156 CYS A 166 HOH A 547 SITE 4 AC5 16 HOH A 600 HOH A 665 HOH A 711 HOH A 764 CRYST1 48.861 70.909 60.417 90.00 109.43 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020466 0.000000 0.007219 0.00000 SCALE2 0.000000 0.014103 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017551 0.00000